Literature DB >> 9024141

A focal source of atrial fibrillation treated by discrete radiofrequency ablation.

P Jaïs1, M Haïssaguerre, D C Shah, S Chouairi, L Gencel, M Hocini, J Clémenty.   

Abstract

BACKGROUND: Atrial fibrillation is usually thought to be due to multiple circulating reentrant wavelets. From previous studies, a focal mechanism is considered to be very unlikely. In this report, focal atrial fibrillation is defined on an ECG pattern of atrial fibrillation and later demonstrated to be due to a focal source. METHODS AND
RESULTS: Nine patients (five men and four women, age, 38 +/- 7 years) with paroxysmal focal atrial fibrillation are reported here. All were free of structural heart disease and had frequent episodes of atrial fibrillation despite the use of a mean of 4 +/- 2 antiarrhythmic drugs. Atrial fibrillation was associated with runs of irregular atrial tachycardia or monomorphic extrasystoles. The electrophysiological study demonstrated that all the atrial arrhythmias were due to the same focus firing irregularly and exhibiting a consistent and centrifugal pattern of activation. Three foci were found to be located in the right atrium, two near the sinus node and one in the ostium of the coronary sinus. Six others were located in the left atrium at the ostium of the right pulmonary veins (n = 5) and at the ostium of the left superior pulmonary vein (n = 1). All atrial arrhythmias were successfully treated by use of a mean of 4 +/- 4 radiofrequency pulses.
CONCLUSIONS: In some patients, the surface ECG pattern of atrial fibrillation is due to a focal rapidly firing source of activity that can be eliminated by discrete radiofrequency energy applications.

Entities:  

Mesh:

Year:  1997        PMID: 9024141     DOI: 10.1161/01.cir.95.3.572

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  178 in total

Review 1.  Novel catheter technology for ablative cure of atrial fibrillation.

Authors:  M D Lesh; P Guerra; F X Roithinger; Y Goseki; C Diederich; W H Nau; M Maguire; K Taylor
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

Review 2.  New devices and hybrid therapies and new devices for treatment of atrial fibrillation.

Authors:  R B Krol; S Saksena; A Prakash
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

Review 3.  Unipolar recording in cardiac electrophysiologic studies.

Authors:  F M Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  1999-07       Impact factor: 1.900

Review 4.  Electrophysiologic study in patients with atrial fibrillation: an idea whose time has come yet again.

Authors:  S Saksena
Journal:  J Interv Card Electrophysiol       Date:  1999-07       Impact factor: 1.900

Review 5.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

6.  Current perspectives on curative catheter ablation of atrial fibrillation.

Authors:  D C Shah; M Haïssaguerre; P Jaïs
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

7.  Architecture of the pulmonary veins: relevance to radiofrequency ablation.

Authors:  S Y Ho; J A Cabrera; V H Tran; J Farré; R H Anderson; D Sánchez-Quintana
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

Review 8.  Endocavitary treatment of atrial fibrillation.

Authors:  S B Olsson; E I Hertervig; O Kongstad; C Meurling; S Yuan
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 9.  Physiology and pathophysiology of the atria: its role in atrial fibrillation.

Authors:  J Godtfredsen
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 10.  Ablation of atrial fibrillation.

Authors:  Eduardo B Saad; Nassir F Marrouche; Andrea Natale
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.